http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-3978229-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C223-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C221-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-18
filingDate 1996-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-3978229-B2
titleOfInvention Method for producing retroviral protease inhibitor intermediate
abstract The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
priorityDate 1995-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00797
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TSZ1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19701
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID147040
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450104
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID469651
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6W228
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DYE7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574299
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID216858
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DLW5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280909
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466414704
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100399036
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5972
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP60016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466450732
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A6I8ST60
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403838
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID102122446
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24715
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19702
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DLS0

Total number of triples: 62.